General Information of the Compound
| Compound ID |
CP0426198
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-[(7-chloro-1,1,3-trioxo-4H-1lambda6,2,4-benzothiadiazin-2-yl)methyl]-N-cyclohexylbenzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C21H22ClN3O4S
|
||||||||||||||||||
| Molecular Weight |
447.944
|
||||||||||||||||||
| Canonical SMILES |
Clc1ccc2NC(=O)N(Cc3ccc(cc3)C(=O)NC3CCCCC3)S(=O)(=O)c2c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C21H22ClN3O4S/c22-16-10-11-18-19(12-16)30(28,29)25(21(27)24-18)13-14-6-8-15(9-7-14)20(26)23-17-4-2-1-3-5-17/h6-12,17H,1-5,13H2,(H,23,26)(H,24,27)
Show/Hide
|
||||||||||||||||||
| InChIKey |
FULPCYISQCGMBW-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01109, 11-beta-hydroxysteroid dehydrogenase 1
Protein ID: PT01107, 11-beta-hydroxysteroid dehydrogenase 1